^
Idylla™ EGFR/BRAF+ Assay is a RUO Assay that will be used for detection of the vast majority of actionable mutations in FFPE samples from patients with NSCLC, including a.o. EGFR, BRAF and KRAS G12C.
Cancer:
Non Small Cell Lung Cancer
Gene:
BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), KRAS (KRAS proto-oncogene GTPase)
Method:
PCR